PPARA and metabolic dysfunction-associated steatohepatitis: In mouse models of metabolic dysfunction-associated steatohepatitis (MASH), activation of peroxisome proliferator-activated receptor alpha (PPARα) has been shown to exert anti-inflammatory effects and may help address various stages of metabolic dysfunction-associated steatotic liver disease (MASLD) [87].